var data={"title":"Candidemia and invasive candidiasis in children: Clinical manifestations and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Candidemia and invasive candidiasis in children: Clinical manifestations and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Judith R Campbell, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Debra L Palazzi, MD, MEd</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Mary M Torchia, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 09, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The term candidemia describes the presence of <em>Candida</em> species in the blood. <em>Candida</em> in a blood culture should prompt a search for the source; it should never be viewed as a contaminant. Invasive candidiasis encompasses both candidemia and deep-seated (ie, visceral) candidiasis (which may occur with or without candidemia) [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The epidemiology, pathogenesis, clinical manifestations, and diagnosis of candidemia and invasive candidiasis in children will be discussed here. An overview of candidal infections and management of candidemia and invasive candidiasis in children, candidal infections in neonates, and candidal infections in adults are discussed separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=candida-infections-in-children\" class=\"medical medical_review\">&quot;Candida infections in children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=candidemia-and-invasive-candidiasis-in-children-management\" class=\"medical medical_review\">&quot;Candidemia and invasive candidiasis in children: Management&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=epidemiology-and-risk-factors-for-candida-infection-in-neonates\" class=\"medical medical_review\">&quot;Epidemiology and risk factors for Candida infection in neonates&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candida-infection-in-neonates\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Candida infection in neonates&quot;</a> and <a href=\"topic.htm?path=treatment-of-candida-infection-in-neonates\" class=\"medical medical_review\">&quot;Treatment of Candida infection in neonates&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-candidemia-in-adults\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of candidemia in adults&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candidemia-and-invasive-candidiasis-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-candidemia-and-invasive-candidiasis-in-adults\" class=\"medical medical_review\">&quot;Treatment of candidemia and invasive candidiasis in adults&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Beyond the neonatal period (ie, in children &gt;28 days),<em> Candida</em> spp are important pathogens in critically ill patients and patients with immunocompromising conditions [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/2,3\" class=\"abstract_t\">2,3</a>]. The epidemiology of <em>Candida</em> infections in neonates is discussed separately. (See <a href=\"topic.htm?path=epidemiology-and-risk-factors-for-candida-infection-in-neonates\" class=\"medical medical_review\">&quot;Epidemiology and risk factors for Candida infection in neonates&quot;</a>.)</p><p>The overall incidence of candidemia in population-based studies ranges from 2 to 14 cases per 100,000 persons [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/4-6\" class=\"abstract_t\">4-6</a>]. The incidence is increased in children younger than one year and in older adults. In population-based surveillance in the United States (2008 to 2011), the annual incidence of candidemia in infants &lt;1 year of age was 34 to 46 per 100,000, compared with &lt;10 per 100,000 in children 1 through 19 years of age [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. In surveillance from a single tertiary care children's hospital, <em>Candida</em> accounted for 5 percent of episodes of bloodstream infections between 2002 and 2012 [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>The infecting strain usually is part of the host's colonizing flora [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>]. Health care-associated acquisition of <em>Candida</em> species has been described, but is rare. In healthcare-associated cases, contaminated solutions and the hands of health care workers have been implicated [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/8,9\" class=\"abstract_t\">8,9</a>].</p><p>The distribution of <em>Candida</em> species causing invasive candidiasis varies geographically and temporally. Nonalbicans species are increasingly isolated at some institutions [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/3,10-15\" class=\"abstract_t\">3,10-15</a>]. In children, <em>C. parapsilosis</em> is the predominant nonalbicans species in most geographic regions [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/16,17\" class=\"abstract_t\">16,17</a>]. In adults, <em>C. glabrata</em> is the predominant nonalbicans species in Canada, northern Europe, and the United States, whereas <em>C. parapsilosis</em> is more prominent in Asia, southern Europe, and South America [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>]. Increasing use of <a href=\"topic.htm?path=fluconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">fluconazole</a> may contribute to the increasing prevalence of nonalbicans species, but other factors may also play a role [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/16\" class=\"abstract_t\">16</a>]. (See <a href=\"topic.htm?path=biology-of-candida-infections#H2\" class=\"medical medical_review\">&quot;Biology of Candida infections&quot;, section on 'Mycology'</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Immunosuppressed children, children in intensive care units, children with central venous catheters, and neonates are most at risk for the development of candidemia. Risk factors in neonates are discussed separately. (See <a href=\"topic.htm?path=epidemiology-and-risk-factors-for-candida-infection-in-neonates#H8\" class=\"medical medical_review\">&quot;Epidemiology and risk factors for Candida infection in neonates&quot;, section on 'Risk factors for invasive candidiasis'</a>.)</p><p>Risk factors for invasive candidiasis in children beyond the neonatal period include [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/2,3,8,12,18-25\" class=\"abstract_t\">2,3,8,12,18-25</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central venous catheter </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immune suppression (eg, hematologic malignancy; solid organ or stem cell transplantation; antineoplastic chemotherapy; neutropenia; long-term glucocorticoids)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Damage to the gastrointestinal mucosa (eg, related to antineoplastic chemotherapy or immune modulators, abdominal surgery, gastrointestinal perforation or anastomotic leak)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Broad-spectrum antibiotics</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Parenteral nutrition</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Renal failure requiring hemodialysis</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mechanical ventilation</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Genetic susceptibility [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/26-28\" class=\"abstract_t\">26-28</a>]</p><p/><p>A multivariate model using several of the above risk factors failed to predict candidemia in a multicenter case control study [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/29\" class=\"abstract_t\">29</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Candida</em> gains access to the bloodstream by three major routes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Through the gastrointestinal tract mucosal barrier (most common mechanism for candidemia) &ndash; <em>Candida</em> species are part of the normal bowel flora; predisposing factors (eg, broad-spectrum antibiotics, immune suppression, gastrointestinal surgery) lead to overgrowth and subsequent leakage into the bloodstream. (See <a href=\"#H3\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Via an intravascular catheter, particularly a central venous catheter &ndash; <em>Candida</em> colonization of the vascular catheter can occur at either the insertion site or the hub and lead to subsequent candidemia. Candidemia that originated in the gut or skin also can colonize the catheter during bloodstream infection. Colonization of the catheter may lead to the formation of a biofilm, from which fungi are subsequently released, resulting in persistent candidemia [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>From a localized focus of infection (eg, pyelonephritis) &ndash; Bloodstream invasion is relatively uncommon from a localized focus of infection but has been well described with ascending <em>Candida</em> urinary tract infection associated with either intrinsic obstruction (eg, from a fungus ball) or extrinsic compression preventing the flow of infected urine. (See <a href=\"topic.htm?path=candida-infections-of-the-bladder-and-kidneys\" class=\"medical medical_review\">&quot;Candida infections of the bladder and kidneys&quot;</a> and <a href=\"topic.htm?path=candida-infections-in-children#H12\" class=\"medical medical_review\">&quot;Candida infections in children&quot;, section on 'Urinary tract infections'</a>.)</p><p/><p class=\"bulletIndent1\"><em>Candida</em> may disseminate from the localized infection, leading to metastatic infections in the lung, liver, spleen, kidneys, bone, or eye (ie, deep-seated infections). Deep-seated infections may remain localized or lead to secondary candidemia [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical manifestations of candidemia and invasive candidiasis vary from minimal fever to a fulminant sepsis with multiorgan system failure that is indistinguishable from severe bacterial infection. In patients with fulminant sepsis, necropsy reveals widespread visceral microabscesses that are especially prominent in the kidneys (<a href=\"image.htm?imageKey=ID%2F52139\" class=\"graphic graphic_picture graphicRef52139 \">picture 1</a>), heart, liver, spleen, lungs, and brain.</p><p>Clinical clues to candidemia include characteristic eye lesions, skin lesions, and, less commonly, muscle abscesses.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chorioretinitis</strong> &ndash; Characteristic chorioretinal findings include focal, glistening, white, infiltrative, often mound-like lesions on the retina (<a href=\"image.htm?imageKey=ID%2F58685\" class=\"graphic graphic_picture graphicRef58685 \">picture 2A</a>). A vitreal haze suggests extension to the vitreous; sometimes fluffy white balls or &quot;snowballs&quot; in the vitreous are noted (<a href=\"image.htm?imageKey=ID%2F73318\" class=\"graphic graphic_picture graphicRef73318 \">picture 2B</a>). (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-fungal-endophthalmitis#H27883763\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis&quot;, section on 'Clinical manifestations'</a>.)</p><p/><p class=\"bulletIndent1\">Chorioretinitis may be seen in children who are immunocompromised; it is more common in neonates. In a retrospective review, among 254 children with candidemia who had a dilated retinal examination, only eight patients (3.2 percent) had ophthalmologic involvement: four with chorioretinitis only and four with involvement of the vitreous in addition to chorioretinitis [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Skin lesions</strong> &ndash; Candidal skin lesions tend to appear suddenly as clusters of painless pustules on an erythematous base; they can occur on any area of the body. The lesions vary from tiny pustules that can be easily missed (<a href=\"image.htm?imageKey=ID%2F55977\" class=\"graphic graphic_picture graphicRef55977 \">picture 3A</a>) to nodular lesions, several centimeters in diameter, which appear necrotic in the center (<a href=\"image.htm?imageKey=ID%2F75717\" class=\"graphic graphic_picture graphicRef75717 \">picture 3B</a>). In severely neutropenic patients, the lesions may be macular rather than pustular.</p><p/><p class=\"bulletIndent1\">Specimens from skin lesions (eg, scrapings from the base of a pustule, punch biopsy) can be obtained for laboratory identification. (See <a href=\"#H11\" class=\"local\">'Culture and stain of biopsy material'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Muscle pain</strong> &ndash; Soreness in a discrete muscle group is less common than chorioretinitis or skin lesions. Examination reveals a tender muscle that may be warm and swollen. Biopsy shows microabscesses in the muscle, and special stains may show budding yeasts.</p><p/><p>Clinical manifestations of deep-seated candidal infections that may or may not be associated with candidemia are described separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Endophthalmitis (see <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-fungal-endophthalmitis\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central nervous system infection (see <a href=\"topic.htm?path=candida-infections-of-the-central-nervous-system\" class=\"medical medical_review\">&quot;Candida infections of the central nervous system&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Endocarditis (see <a href=\"topic.htm?path=candida-endocarditis-and-suppurative-thrombophlebitis\" class=\"medical medical_review\">&quot;Candida endocarditis and suppurative thrombophlebitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Osteoarticular infections (see <a href=\"topic.htm?path=candida-osteoarticular-infections\" class=\"medical medical_review\">&quot;Candida osteoarticular infections&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic disseminated candidiasis (see <a href=\"topic.htm?path=chronic-disseminated-candidiasis-hepatosplenic-candidiasis\" class=\"medical medical_review\">&quot;Chronic disseminated candidiasis (hepatosplenic candidiasis)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H2223395804\"><span class=\"h2\">Clinical suspicion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although many children with invasive candidiasis have no obvious clinical manifestations, we suspect candidemia or invasive candidiasis in children with risk factors who have [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Unexplained fever or signs of severe sepsis while receiving adequate antibiotics</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin lesions suggestive of invasive candidiasis (eg, multiple, nontender, erythematous, pustular or nodular lesions (<a href=\"image.htm?imageKey=ID%2F55977%7EID%2F75717\" class=\"graphic graphic_picture graphicRef55977 graphicRef75717 \">picture 3A-B</a>))</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eye findings suggestive of invasive candidiasis (<a href=\"image.htm?imageKey=ID%2F58685%7EID%2F73318\" class=\"graphic graphic_picture graphicRef58685 graphicRef73318 \">picture 2A-B</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multiple focal liver or spleen lesions on imaging for persistent fever [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/32,33\" class=\"abstract_t\">32,33</a>] &#160;</p><p/><p>Decisions regarding empiric treatment with antifungal therapy in children with suspected candidemia (whether or not they have suggestive examination findings) are discussed separately. (See <a href=\"topic.htm?path=candidemia-and-invasive-candidiasis-in-children-management#H1402641259\" class=\"medical medical_review\">&quot;Candidemia and invasive candidiasis in children: Management&quot;, section on 'Empiric antifungal therapy for at-risk patients'</a>.)</p><p class=\"headingAnchor\" id=\"H4110221919\"><span class=\"h2\">Approach to laboratory diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The tests available to detect invasive candidiasis have important limitations; accurate diagnosis may require multiple tests [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/1,6,34\" class=\"abstract_t\">1,6,34</a>].</p><p>We suggest the following approach to laboratory diagnosis in children with suspected candidemia:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>All patients &ndash; Obtain blood cultures (routine bacterial cultures) of adequate volume based on the patient's weight from peripheral and central catheters whenever feasible. Repeat daily blood cultures are of limited clinical utility if the initial set of cultures are of adequate volume and the patient's clinical condition is unchanged. The sensitivity of detection varies by pathogen and disease [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/35\" class=\"abstract_t\">35</a>], as well as blood culture volume. The optimal volume for detection of <em>Candida</em> is not known. However, general guidelines for adequate volume of blood (total volume, divided in two bottles) according to weight are as follows [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/36\" class=\"abstract_t\">36</a>]: &#160;</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&le;3.9 kg (8.6 pounds) &ndash; 1 mL</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>4 to 7.9 kg (8.8 to 17.4 pounds) &ndash; 3 mL</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>8 to 13.9 kg (17.6 to 30.6 pounds) &ndash; 6 mL</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>14 to 18.9 kg (30.8 to 41.7 pounds) &ndash; 12 mL</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>19 to 25.9 kg (41.9 to 57.1 pounds) &ndash; 16 mL</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>26 to 39.9 kg (57.3 to 88 pounds) &ndash; 20 mL</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>40 to 53.9 kg (88.2 to 118.8 pounds) &ndash; 8 mL</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&ge;54 kg (119 pounds) &ndash; 40 mL </p><p/><p class=\"bulletIndent1\">(See <a href=\"#H10\" class=\"local\">'Blood cultures'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with pustules or other skin lesions (<a href=\"image.htm?imageKey=ID%2F55977%7EID%2F75717\" class=\"graphic graphic_picture graphicRef55977 graphicRef75717 \">picture 3A-B</a>) &ndash; Scrape the base of the pustule with a scalpel and submit obtained material for Gram stain and culture. Obtain a punch biopsy for culture, fungal stains, and histopathologic examination.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with parenchymal involvement &ndash; Obtain biopsy for culture, fungal stains, and histopathologic examination.</p><p/><p class=\"headingAnchor\" id=\"H3028289430\"><span class=\"h2\">Microbiologic studies</span></p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Blood cultures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A blood culture positive for <em>Candida</em> is the reference standard for the diagnosis of candidemia. Culture is the only method that allows susceptibility testing. <em>Candida</em> in a blood culture should prompt immediate treatment and a search for the source (eg, central venous catheter, gastrointestinal tract, deep-seated infection); it should never be viewed as a contaminant. (See <a href=\"topic.htm?path=candidemia-and-invasive-candidiasis-in-children-management#H11\" class=\"medical medical_review\">&quot;Candidemia and invasive candidiasis in children: Management&quot;, section on 'Choice of antifungal therapy'</a>.)</p><p><em>Candida</em> can be detected with blood culture systems commonly used for the detection of bacteria, but the reported sensitivity can be low. In studies performed before the advent of modern blood culture techniques, blood cultures were positive in only approximately 50 percent of patients found to have disseminated candidiasis at autopsy [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Similar autopsy-based studies have not been reported since the advent of modern blood culture techniques (eg, lysis-centrifugation [Dupont Isolator tube], changes in culture media used in the BACTEC and BactiAlert systems). However, with newer automated blood culture systems and weight-based recommendations for obtaining appropriate volumes of blood for culture, the rate of detection likely is improved.</p><p>It can take several days to establish the diagnosis of candidemia with blood cultures: one to two days for the <em>Candida</em> to grow and another one to two days for speciation [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. New techniques are helping to shorten the interval to identification:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH) technology is a commercially available system that can identify yeasts as being <em>C. albicans</em> or <em>C. glabrata</em> within two hours of obtaining a positive blood culture [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/38\" class=\"abstract_t\">38</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) identifies protein patterns of many types of organisms accurately and quickly and is increasingly used for the rapid identification of <em>Candida </em>species isolated from blood cultures [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/39\" class=\"abstract_t\">39</a>].</p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Culture and stain of biopsy material</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Culture or histopathologic examination of biopsy samples from skin or other sites of involvement may lead to identification of <em>Candida</em>. Gram stain may demonstrate budding yeast (<a href=\"image.htm?imageKey=ID%2F70812\" class=\"graphic graphic_picture graphicRef70812 \">picture 4</a>). Punch biopsies of skin or tissue biopsy will show microabscesses, and special stains for fungi (eg, Gomori methenamine silver, periodic acid-Schiff) will show budding yeasts and sometimes pseudohyphae or hyphae characteristic of <em>Candida</em>.</p><p>Isolation of <em>Candida</em> from skin or parenchymal biopsy is a reference standard for the diagnosis of candidiasis. As with blood cultures, the sensitivity of cultures from parenchymal samples is relatively low, reflecting the difficulties in choosing the best site for sampling and the variability in distribution and burden of viable organisms [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Nonculture methods</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nonculture methods include beta-D-glucan and other antigen assays and polymerase chain reaction (PCR). Nonculture methods, alone or in combination with blood cultures may increase the identification of invasive candidiasis [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. However, these methods are not well studied in children and we generally do not use them. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Specific for </strong><strong><em>Candida</em></strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Commercial PCR assays</strong> &ndash; The T2Candida is a US Food and Drug Administration (FDA)-approved magnetic resonance-based system that is able to detect <em>Candida</em> colony-forming units and identify <em>Candida</em> species directly from blood cultures within as few as three to five hours [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/40-42\" class=\"abstract_t\">40-42</a>], but further study of the clinical utility in children is necessary. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candidemia-and-invasive-candidiasis-in-adults#H3499818720\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults&quot;, section on 'T2Candida'</a>.)</p><p/><p class=\"bulletIndent2\">The Septifast assay is another commercially available rapid PCR test that can be used on whole blood without preculture to detect and identify <em>Candida</em> species within six hours. However, it is unavailable in the United States and requires further study in children.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Noncommercial PCR assay</strong> &ndash; Experience with PCR assays for invasive candidiasis in children is limited. PCR assays can identify individual species of <em>Candida</em>. However, a standardized PCR assay for <em>Candida</em> that has been validated in multicenter studies is not yet available.</p><p/><p class=\"bulletIndent2\">The reported sensitivity of noncommercial (&quot;in-house&quot;) PCR assays for the detection of candidemia is similar to that of blood cultures; however, in occasional cases PCR helped to establish the diagnosis of invasive candidiasis when cultures were negative [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/34,43-45\" class=\"abstract_t\">34,43-45</a>].</p><p/><p class=\"bulletIndent2\">Newer real-time PCR assays appear to be more sensitive than blood cultures and the beta-D-glucan assay in detecting invasive candidiasis in adult patients [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/34\" class=\"abstract_t\">34</a>]; combining PCR with blood cultures may further increase the sensitivity.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Antigen and antibody assays</strong> &ndash; Assays for several <em>Candida</em> cell wall components (eg, mannan), cytoplasmic antigens, and the metabolite arabinitol have been investigated, but are not sufficiently sensitive for diagnosis invasive candidiasis [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/46-49\" class=\"abstract_t\">46-49</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Not specific for </strong><strong><em>Candida</em></strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Beta-D-glucan</strong> &ndash; Experience with beta-D-glucan assays for the diagnosis of candidemia in children is limited.</p><p/><p class=\"bulletIndent2\">Beta-D-glucan is present in the cell wall of many fungi, including <em>Candida</em>. An assay that detects beta-D-glucan is commercially available and increasingly used in the diagnosis of fungal infections [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/50-53\" class=\"abstract_t\">50-53</a>]. Although the beta-D-glucan assay is sensitive in detecting invasive fungal infections (75 to 80 percent) [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/54\" class=\"abstract_t\">54</a>], and in patients with candidemia (approximately 80 percent) [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/51\" class=\"abstract_t\">51</a>], it is not specific for <em>Candida</em>; a positive test requires identification of the infecting organism [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p class=\"headingAnchor\" id=\"H3210288907\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The major considerations in the differential diagnosis of candidemia and invasive candidiasis include bacterial sepsis and localized bacterial infection (eg, endocarditis). Bacterial and candidal sepsis or focal infection cannot be differentiated clinically. Microbiologic evaluation is necessary to establish the diagnosis. (See <a href=\"topic.htm?path=systemic-inflammatory-response-syndrome-sirs-and-sepsis-in-children-definitions-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis&quot;</a>.)</p><p>Pustular skin lesions, which may be suggestive of candidemia (<a href=\"image.htm?imageKey=ID%2F55977%7EID%2F75717\" class=\"graphic graphic_picture graphicRef55977 graphicRef75717 \">picture 3A-B</a>), occur in other infectious and noninfectious conditions. The skin lesions of candidemia usually are painless, but painlessness is nonspecific and Gram stain, culture, or histopathologic examination may be necessary to establish a diagnosis. (See <a href=\"topic.htm?path=approach-to-the-patient-with-pustular-skin-lesions\" class=\"medical medical_review\">&quot;Approach to the patient with pustular skin lesions&quot;</a>.)</p><p>Endophthalmitis, another finding suggestive of candidemia (<a href=\"image.htm?imageKey=ID%2F58685%7EID%2F73318\" class=\"graphic graphic_picture graphicRef58685 graphicRef73318 \">picture 2A-B</a>), may be caused by bacteria and other fungi. Cultures, special stains, and other microbiologic studies are necessary to establish the diagnosis. (See <a href=\"topic.htm?path=bacterial-endophthalmitis#H7\" class=\"medical medical_review\">&quot;Bacterial endophthalmitis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-fungal-endophthalmitis#H27883777\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">ADDITIONAL EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Once blood cultures are positive, confirming the diagnosis of candidemia, children who are immune compromised or critically ill generally should undergo a formal ophthalmologic examination, whether or not they have ocular symptoms [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/30,55-57\" class=\"abstract_t\">30,55-57</a>]. Ophthalmologic examination may not be warranted for immune competent children with a single positive culture who respond rapidly to antifungal therapy. </p><p>In neutropenic patients the eye examination should be performed within a week of neutrophil recovery because findings may be minimal during the period of neutropenia [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/57\" class=\"abstract_t\">57</a>]. Sight-threatening ocular abnormalities, including chorioretinitis and endophthalmitis, may occur in as many as 8 percent of children with candidemia [<a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/30,58\" class=\"abstract_t\">30,58</a>].</p><p>In children with invasive candidiasis without candidemia, the decision regarding whether to perform an ophthalmologic examination is based on the patient's clinical course, immune status, and associated symptoms.</p><p>The evaluation of neonates with candidemia is discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candida-infection-in-neonates\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Candida infection in neonates&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3470923359\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-candidiasis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Candidiasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3939823\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The term candidemia describes the presence of <em>Candida</em> species in the blood. <em>Candida</em> in a blood culture should prompt a search for the source; it should never be viewed as a contaminant. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the neonatal period (ie, in children &gt;28 days),<em> Candida</em> spp are important pathogens in critically ill patients and patients with immunocompromising conditions. The incidence of invasive candidiasis is increased in children younger than one year. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The infecting strain is usually part of the host's colonizing flora. The distribution of <em>Candida</em> species causing invasive candidiasis varies geographically. <em>C. albicans</em> is most common, but nonalbicans species are increasingly isolated. In children, <em>C. parapsilosis</em> is the predominant nonalbicans species in most geographic regions. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Risk factors for invasive candidiasis include immune suppression, damage to the gastrointestinal mucosa, antineoplastic chemotherapy, central venous catheter, receipt of broad-spectrum antibiotics, parenteral nutrition, renal failure requiring hemodialysis, and mechanical ventilation. (See <a href=\"#H3\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although many children with invasive candidiasis have no obvious clinical manifestations, we suspect invasive candidiasis in children with risk factors who have:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Unexplained fever or signs of severe sepsis while receiving adequate antibiotics</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Skin lesions suggestive of invasive candidiasis (eg, multiple, nontender, erythematous, pustular or nodular lesions (<a href=\"image.htm?imageKey=ID%2F55977%7EID%2F75717\" class=\"graphic graphic_picture graphicRef55977 graphicRef75717 \">picture 3A-B</a>))</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Eye findings suggestive of invasive candidiasis (<a href=\"image.htm?imageKey=ID%2F58685%7EID%2F73318\" class=\"graphic graphic_picture graphicRef58685 graphicRef73318 \">picture 2A-B</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Multiple focal liver or spleen lesions on imaging for persistent fever </p><p/><p class=\"bulletIndent1\">(See <a href=\"#H8\" class=\"local\">'Clinical manifestations'</a> above and <a href=\"#H2223395804\" class=\"local\">'Clinical suspicion'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The tests available to detect invasive candidiasis have important limitations; accurate diagnosis may require multiple tests. We obtain blood cultures of adequate volume from all patients with suspected invasive candidiasis, and other specimens for culture or biopsy as indicated (eg, scrapings from the base of pustules for Gram stain and culture, biopsy of skin or other focal lesions for culture, fungal stains, and histopathologic examination). (See <a href=\"#H4110221919\" class=\"local\">'Approach to laboratory diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A blood culture positive for <em>Candida</em> is the reference standard for the diagnosis of candidemia. Historically, the sensitivity of blood cultures in detecting invasive candidiasis was relatively low (approximately 50 percent). With newer automated blood culture systems and weight-based recommendations for obtaining appropriate volumes of blood for culture, the rate of detection likely is improved. <em>Candida</em> in a blood culture should prompt immediate treatment and a search for the source (eg, central venous catheter, gastrointestinal tract, deep-seated infection). (See <a href=\"#H10\" class=\"local\">'Blood cultures'</a> above and <a href=\"topic.htm?path=candidemia-and-invasive-candidiasis-in-children-management#H11\" class=\"medical medical_review\">&quot;Candidemia and invasive candidiasis in children: Management&quot;, section on 'Choice of antifungal therapy'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants and children with candidemia who are immune compromised or critically ill generally should undergo a formal ophthalmologic examination for chorioretinitis, whether or not they have ocular symptoms. (See <a href=\"#H14\" class=\"local\">'Additional evaluation'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H1592359163\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Carol A Kauffman, MD, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Clancy CJ, Nguyen MH. Finding the &quot;missing 50%&quot; of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56:1284.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20:571.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Blyth CC, Chen SC, Slavin MA, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009; 123:1360.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55:1352.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care 2010; 16:445.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med 2015; 373:1445.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Larru B, Gong W, Vendetti N, et al. Bloodstream Infections in Hospitalized Children: Epidemiology and Antimicrobial Susceptibilities. Pediatr Infect Dis J 2016; 35:507.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis 1999; 34:213.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20:133.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Trofa D, G&aacute;cser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21:606.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol 2006; 44:1782.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G. Nosocomial candidaemia in children: results of a 9-year study. Mycoses 2008; 51:248.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J 2011; 30:664.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Dotis J, Prasad PA, Zaoutis T, Roilides E. Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children. Pediatr Infect Dis J 2012; 31:557.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Steinbach WJ, Roilides E, Berman D, et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J 2012; 31:1252.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Oeser C, Lamagni T, Heath PT, et al. The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. Pediatr Infect Dis J 2013; 32:23.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Palazzi DL, Arrieta A, Castagnola E, et al. Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multi-national study. Pediatr Infect Dis J 2014; 33:1294.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33:177.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Playford EG, Marriott D, Nguyen Q, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 2008; 36:2034.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28:1071.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Chow JK, Golan Y, Ruthazer R, et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008; 36:1993.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008; 46:1206.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 2010; 51:e38.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20:1526.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Plantinga TS, Johnson MD, Scott WK, et al. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 2012; 205:934.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Kumar V, Cheng SC, Johnson MD, et al. Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. Nat Commun 2014; 5:4675.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Johnson MD, Plantinga TS, van de Vosse E, et al. Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis 2012; 54:502.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Fisher BT, Ross RK, Roilides E, et al. Failure to Validate a Multivariable Clinical Prediction Model to Identify Pediatric Intensive Care Unit Patients at High Risk for Candidemia. J Pediatric Infect Dis Soc 2016; 5:458.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Fierro JL, Prasad PA, Fisher BT, et al. Ocular manifestations of candidemia in children. Pediatr Infect Dis J 2013; 32:84.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Singhi S, Deep A. Invasive candidiasis in pediatric intensive care units. Indian J Pediatr 2009; 76:1033.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Hegde SV, Dillman JR, Lopez MJ, Strouse PJ. Imaging of multifocal liver lesions in children and adolescents. Cancer Imaging 2013; 12:516.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Yen TY, Huang LM, Lee PI, et al. Clinical characteristics of hepatosplenic fungal infection in pediatric patients. J Microbiol Immunol Infect 2011; 44:296.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, &beta;-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54:1240.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Buttery JP. Blood cultures in newborns and children: optimising an everyday test. Arch Dis Child Fetal Neonatal Ed 2002; 87:F25.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Gonsalves WI, Cornish N, Moore M, et al. Effects of volume and site of blood draw on blood culture results. J Clin Microbiol 2009; 47:3482.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Schelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. J Pediatr 2003; 142:564.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Shepard JR, Addison RM, Alexander BD, et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46:50.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev 2014; 27:490.</a></li><li class=\"breakAll\">US Food and Drug Administration. FDA news release. FDA allows marketing of the first test to identify five yeast pathogens directly from a blood sample. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm415728.htm (Accessed on September 24, 2014).</li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 2013; 5:182ra54.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis 2015; 60:892.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40:2483.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46:890.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Lau A, Halliday C, Chen SC, et al. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 2010; 48:811.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Matthews RC. Comparative assessment of the detection of candidal antigens as a diagnostic tool. J Med Vet Mycol 1996; 34:1.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Reiss E, Obayashi T, Orle K, et al. Non-culture based diagnostic tests for mycotic infections. Med Mycol 2000; 38 Suppl 1:147.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Steinbach WJ. Blood-based Diagnosis of Invasive Fungal Infections in Immunocompromised/Oncology Patients. Pediatr Infect Dis J 2015; 34:1020.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Marchetti O, Lamoth F, Mikulska M, et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47:846.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1--&gt;3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46:1864.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Mohr JF, Sims C, Paetznick V, et al. Prospective survey of (1&rarr;3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011; 49:58.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. &beta;-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011; 52:750.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Krishna R, Amuh D, Lowder CY, et al. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye (Lond) 2000; 14 ( Pt 1):30.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Enzenauer RW, Calderwood S, Levin AV, et al. Screening for fungal endophthalmitis in children at risk. Pediatrics 1992; 90:451.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</a></li><li><a href=\"https://www.uptodate.com/contents/candidemia-and-invasive-candidiasis-in-children-clinical-manifestations-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Zaoutis TE, Greves HM, Lautenbach E, et al. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004; 23:635.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5976 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H3939823\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">RISK FACTORS</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">PATHOGENESIS</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">DIAGNOSIS</a><ul><li><a href=\"#H2223395804\" id=\"outline-link-H2223395804\">Clinical suspicion</a></li><li><a href=\"#H4110221919\" id=\"outline-link-H4110221919\">Approach to laboratory diagnosis</a></li><li><a href=\"#H3028289430\" id=\"outline-link-H3028289430\">Microbiologic studies</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Blood cultures</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Culture and stain of biopsy material</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Nonculture methods</a></li></ul></li></ul></li><li><a href=\"#H3210288907\" id=\"outline-link-H3210288907\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">ADDITIONAL EVALUATION</a></li><li><a href=\"#H3470923359\" id=\"outline-link-H3470923359\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H3939823\" id=\"outline-link-H3939823\">SUMMARY</a></li><li><a href=\"#H1592359163\" id=\"outline-link-H1592359163\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/5976|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/52139\" class=\"graphic graphic_picture\">- Disseminated candidiasis kidney</a></li><li><a href=\"image.htm?imageKey=ID/58685\" class=\"graphic graphic_picture\">- Candida endophthalmitis</a></li><li><a href=\"image.htm?imageKey=ID/73318\" class=\"graphic graphic_picture\">- Vitritis in endophthalmitis</a></li><li><a href=\"image.htm?imageKey=ID/55977\" class=\"graphic graphic_picture\">- Disseminated candidiasis skin</a></li><li><a href=\"image.htm?imageKey=ID/75717\" class=\"graphic graphic_picture\">- Disseminated candidiasis nodule</a></li><li><a href=\"image.htm?imageKey=ID/70812\" class=\"graphic graphic_picture\">- Budding yeast Gram stain</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-pustular-skin-lesions\" class=\"medical medical_review\">Approach to the patient with pustular skin lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-endophthalmitis\" class=\"medical medical_review\">Bacterial endophthalmitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=biology-of-candida-infections\" class=\"medical medical_review\">Biology of Candida infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candida-endocarditis-and-suppurative-thrombophlebitis\" class=\"medical medical_review\">Candida endocarditis and suppurative thrombophlebitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candida-infections-in-children\" class=\"medical medical_review\">Candida infections in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candida-infections-of-the-bladder-and-kidneys\" class=\"medical medical_review\">Candida infections of the bladder and kidneys</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candida-infections-of-the-central-nervous-system\" class=\"medical medical_review\">Candida infections of the central nervous system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candida-osteoarticular-infections\" class=\"medical medical_review\">Candida osteoarticular infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candidemia-and-invasive-candidiasis-in-children-management\" class=\"medical medical_review\">Candidemia and invasive candidiasis in children: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-disseminated-candidiasis-hepatosplenic-candidiasis\" class=\"medical medical_review\">Chronic disseminated candidiasis (hepatosplenic candidiasis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candida-infection-in-neonates\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Candida infection in neonates</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candidemia-and-invasive-candidiasis-in-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-candidemia-in-adults\" class=\"medical medical_review\">Epidemiology and pathogenesis of candidemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-risk-factors-for-candida-infection-in-neonates\" class=\"medical medical_review\">Epidemiology and risk factors for Candida infection in neonates</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-fungal-endophthalmitis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-candidiasis\" class=\"medical medical_society_guidelines\">Society guideline links: Candidiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=systemic-inflammatory-response-syndrome-sirs-and-sepsis-in-children-definitions-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-candida-infection-in-neonates\" class=\"medical medical_review\">Treatment of Candida infection in neonates</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-candidemia-and-invasive-candidiasis-in-adults\" class=\"medical medical_review\">Treatment of candidemia and invasive candidiasis in adults</a></li></ul></div></div>","javascript":null}